Sustained Revenue GrowthConsistent double-digit top-line expansion demonstrates sustained demand and expanding market penetration. Over a 2–6 month horizon this growth supports scale advantages, revenue visibility and the ability to reinvest in distribution or services to further entrench the business model.

Improving Gross Profit MarginRising gross margin indicates improving cost control or pricing power within core operations. Margin expansion is a durable operational improvement that supports sustainable EBITDA generation, provides cushion for SG&A or investment, and helps the company withstand sector cost pressures.

Healthy Solvency And Falling D/EA strong equity ratio and declining debt-to-equity reflect prudent capital structure and solvency. This durable balance sheet strength enhances financing flexibility for capex or acquisitions, lowers refinancing risk, and supports resilience through industry cycles.

Bears Say

Sharp Decline In Operating Cash FlowA severe drop in operating cash flow and free cash flow weakens the firm's ability to self-fund growth, dividends, or debt service. If persistent, reduced cash generation constrains strategic flexibility, increases reliance on external financing, and heightens vulnerability to cyclical shocks.

Low Net Profit MarginA sub-3% net margin limits retained earnings and the company's buffer against cost shocks or unexpected expenses. Over months, thin net profitability constrains reinvestment capacity and makes earnings sensitive to modest revenue or cost fluctuations, reducing long-term earnings durability.

Significant Absolute Debt LevelDespite improving ratios, a sizable absolute debt stock raises refinancing and interest-rate exposure. Coupled with weaker cash flow and modest net margins, material debt increases financial leverage risk and could limit capital allocation or force constrained deleveraging actions over coming quarters.

3353 FAQ

What was Medical Ikkou Group Co., Ltd.’s price range in the past 12 months?

Medical Ikkou Group Co., Ltd. lowest stock price was ¥2120.00 and its highest was ¥4410.00 in the past 12 months.

What is Medical Ikkou Group Co., Ltd.’s market cap?

Medical Ikkou Group Co., Ltd.’s market cap is ¥10.19B.

When is Medical Ikkou Group Co., Ltd.’s upcoming earnings report date?

Medical Ikkou Group Co., Ltd.’s upcoming earnings report date is Apr 06, 2026 which is in 30 days.

How were Medical Ikkou Group Co., Ltd.’s earnings last quarter?

Medical Ikkou Group Co., Ltd. released its earnings results on Jan 09, 2026. The company reported ¥74.34 earnings per share for the quarter, beating the consensus estimate of N/A by ¥74.34.

Is Medical Ikkou Group Co., Ltd. overvalued?

According to Wall Street analysts Medical Ikkou Group Co., Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Medical Ikkou Group Co., Ltd. pay dividends?

Medical Ikkou Group Co., Ltd. pays a Semiannually dividend of ¥60 which represents an annual dividend yield of 3.51%. See more information on Medical Ikkou Group Co., Ltd. dividends here

What is Medical Ikkou Group Co., Ltd.’s EPS estimate?

Medical Ikkou Group Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Medical Ikkou Group Co., Ltd. have?

Medical Ikkou Group Co., Ltd. has 3,770,000 shares outstanding.

What happened to Medical Ikkou Group Co., Ltd.’s price movement after its last earnings report?

Medical Ikkou Group Co., Ltd. reported an EPS of ¥74.34 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.169%.

Which hedge fund is a major shareholder of Medical Ikkou Group Co., Ltd.?

Currently, no hedge funds are holding shares in JP:3353

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Medical Ikkou Group Co., Ltd.

Medical Ikkou Group Co.,Ltd. operates dispensing pharmacies in Japan. The company is also involved in the operation of nursing homes, outpatient nursing care facilities, and home-visit nursing care facilities; wholesale of generic drugs; and rental of real estate properties, as well as invests in listed and unlisted stocks, M&A, etc. It operates 93 dispensing pharmacy stores. The company was founded in 1980 and is headquartered in Tsu, Japan.